XML 15 R5.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Treasury
Additional Paid-In Capital
Retained Earnings
Noncontrolling Interest Non Redeemable
Net Equity [Member]
Beginning balance, Amount at Dec. 31, 2017 $ 506,591 $ 226 $ (42,249) $ 126,490 $ 364,401 $ 57,723  
Beginning balance (in shares) at Dec. 31, 2017   22,640,046          
Beginning balance, Treasury (in shares) at Dec. 31, 2017     4,890,504        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income [1] 5,592       4,995 597  
Acquired noncontrolling interest 1,235         1,235  
Noncontrolling interest distributions (615)         (615)  
Sale of noncontrolling interest       (2,029)   5,583 $ 3,554
NCI acquired, net of sales       (44)   (12) $ (56)
Nonvested stock compensation 1,601     1,601      
Restricted share grants   $ 2   (2)      
Restricted stock vesting (in shares)   165,567          
Treasury shares redeemed to pay income tax (3,467)   $ (3,467) 0      
Treasury shares redeemed to pay income tax (in shares)     56,772        
Issuance of common stock under Employee Stock Purchase Plan 332 $ 0   332      
Issuance of common stock under Employee Stock Purchase Plan (in shares)   5,534          
Ending balance, Amount at Mar. 31, 2018 514,767 $ 228 $ (45,716) 126,348 369,396 64,511  
Ending balance (in shares) at Mar. 31, 2018   22,811,147          
Ending balance, Treasury (in shares) at Mar. 31, 2018     4,947,276        
Beginning balance, Amount at Dec. 31, 2018 $ 1,424,474 $ 356 $ (49,374) 937,968 427,975 107,549  
Beginning balance (in shares) at Dec. 31, 2018   35,636,414          
Beginning balance, Treasury (in shares) at Dec. 31, 2018 (4,958,721)   4,958,721        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income [1] $ 20,542       18,856 1,686  
Acquired noncontrolling interest 820         820  
Noncontrolling interest distributions (6,799)         (6,799)  
NCI acquired, net of sales (18,000)         (18,000)  
Nonvested stock compensation 1,804     1,804      
Restricted share grants 2 $ 2   0      
Restricted stock vesting (in shares)   174,562          
Treasury shares redeemed to pay income tax $ (7,692)   $ (7,577) (115)      
Treasury shares redeemed to pay income tax (in shares) (59,967)   85,509        
Issuance of common stock under Employee Stock Purchase Plan $ 478 $ 0   478      
Issuance of common stock under Employee Stock Purchase Plan (in shares) 5,357 5,357          
Ending balance, Amount at Mar. 31, 2019 $ 1,415,629 $ 358 $ (56,951) $ 940,135 $ 446,831 $ 85,256  
Ending balance (in shares) at Mar. 31, 2019   35,816,333          
Ending balance, Treasury (in shares) at Mar. 31, 2019 (5,044,230)   5,044,230        
[1] Net income excludes net income attributable to noncontrolling interest-redeemable of $2.9 million and $2.4 million during the three months ending March 31, 2019 and 2018, respectively. Noncontrolling interest-redeemable is reflected outside of permanent equity on the condensed consolidated balance sheets. See Note 8 of the Notes to Condensed Consolidated Financial Statements.